Breaking barriers in rare disease drug development

Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data have historically slowed progress. But the landscape is changing. This infographic explores the key barriers in rare disease drug […]